AI could help heart surgery patients get the right Anti-Inflammatory drug
NCT ID NCT07583290
First seen May 14, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study looks at data from 10,000 heart surgery patients to build an AI tool that helps doctors decide who will benefit from a drug called ulinastatin. The drug may reduce inflammation and complications after surgery, but it doesn't work for everyone. The goal is to match the right patients with the right treatment to improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Cardiac Surgery and Critical Care
Beijing, China
Conditions
Explore the condition pages connected to this study.